Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-01-15
1989-05-02
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514547, 514548, 514622, 514893, 514894, 549450, 560105, 564170, A61K 3165, C07C 6916, C07C10326, C07D31712
Patent
active
048268739
ABSTRACT:
Compounds of the general formula ##STR1## wherein R.sub.1 represents hydrogen, an acyl group having 1 to 18 carbon atoms or both R.sub.1 together the group ##STR2## R.sub.2 represents hydrogen or a methyl group, have been isolated in small amounts from the leaves of Clausena lansium. The new compounds are to be used for the production of compositions for the use of the treatment of acute and chronical viral hepatitis, liver intoxication, hypoxia or amnesia.
REFERENCES:
patent: 2320497 (1943-06-01), Wenner
patent: 2721214 (1955-10-01), Troutman
patent: 2812363 (1957-11-01), Mills
patent: 4341718 (1982-07-01), Kim et al.
patent: 4518789 (1985-05-01), Yu et al.
Prakash et al, Indian J. Chem., vol. 19B, pp. 1075 to 1076 (1980).
Chen Yan-rong
Huang Liang
Liu Geng-tao
Yang Ming-he
Bayer Aktiengesellschaft
Chinese Academy of Medical Sciences
Higel Floyd D.
LandOfFree
2,3-dihydroxy-3-phenyl-N-(2-phenyl-ethyl)-propionic acid amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-dihydroxy-3-phenyl-N-(2-phenyl-ethyl)-propionic acid amides , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-dihydroxy-3-phenyl-N-(2-phenyl-ethyl)-propionic acid amides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-585418